Paul Edward Wheeler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Po Box 1059, Boise City, OK 73933 Phone: 580-517-1057 Fax: 888-651-9957 |
News Archive
Pro-Pharmaceuticals, Inc., a developer of galectin-targeted, carbohydrate therapeutic compounds to treat cancer and fibrosis, today reported its financial results for the third quarter and first nine months of fiscal 2009. These results are included in the Company's Quarterly Report on Form 10-Q for the three- and nine-month periods ended September 30, 2009, which has been filed with the SEC.
By studying the intricate mechanisms at work in protein production, a Princeton-led team has discovered why certain kinds of antibiotics are so effective. In doing so, they also have discovered how one protein protects against cell death, shedding light on a natural cancer-fighting process.
Researchers at Massachusetts General Hospital (MGH) have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient's risk for developing breast cancer with greater accuracy than traditional risk assessment tools.
New York-Presbyterian Hospital's Westchester Division (NYPH) will participate in a National Institute of Mental Health (NIMH) clinical research study of anorexia nervosa, the serious and potentially lethal eating disorder that mostly afflicts teenage girls.
› Verified 7 days ago